510(k) Report

510(k) · Cleared

Cleared

Arthrex iBalance TKA System

K152252510(k) TraditionalCleared Nov 16, 201598-day reviewClass II21 CFR 888.3565

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Arthrex, Inc. · MBH Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer

Cleared on Nov 16, 2015 as substantially equivalent to K081127 (Accelerated Innovation, LLC, 2008) and 1 other predicate after a 98-day review. Its family tree reaches back 7 generations to 1995. 2 later devices descend from it.

Decided
Nov 16, 2015
Review
98 days
Class
Class II
Product code
MBH
Recalls
None
Predicates
2

Its longest line of descent runs back 7 generations to K933785 (1995). 19 ancestors in all. 2 later devices descend from it, 2 citing it directly.

  1. Root · 7 generations backK933785 Next Generation Knee SystemZimmer, Inc. · 1995 · Recalled
  2. 6 generations backK023211 Nexgen Complete Knee Solution Cruciate Retaining (CR)-Flex Femoral…Zimmer, Inc. · 2002 · Recalled
  3. 5 generations backK060370 Nexgen Knee Gender Solutions Female (GSF) Femoral ComponentsZimmer, Inc. · 2006 · Recalled
  4. 4 generations backK070214 Gender Solutions Natural-Knee Flex SystemZimmer, Inc. · 2007 · Recalled
  5. 3 generations backK073286 Gender Solutions Natural-Knee Flex SystemZimmer, Inc. · 2008 · Recalled
  6. 2 generations backK113369 Zimmer Persona Knee SystemZimmer, Inc. · 2012 · Recalled
  7. 1 generation backK122765 Persona Natural Tibia BaseplatesZimmer, Inc. · 2012 · Recalled
  8. This deviceK152252 Arthrex iBalance TKA SystemArthrex, Inc. · 2015
  9. Descendant · cites it directly · 1 of its ownK153586 Arthrex iBalance TKA SystemArthrex, Inc. · 2016
  10. Descendant · cites it directly · 0 of its ownK171365 Arthrex Knee SystemsArthrex, Inc. · 2017

Most influential descendants

Showing 2 of 2 · See all
  • K153586Arthrex iBalance TKA SystemArthrex, Inc. · 2016 · cites it directly1descendant
  • K171365Arthrex Knee SystemsArthrex, Inc. · 2017 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K933785Next Generation Knee SystemZimmer, Inc.199583
−6K023211Nexgen Complete Knee Solution Cruciate Retaining (CR)-Flex Femoral ComponentsZimmer, Inc.20026
−5K060370Nexgen Knee Gender Solutions Female (GSF) Femoral ComponentsZimmer, Inc.200617
−4K070214Gender Solutions Natural-Knee Flex SystemZimmer, Inc.200763
−3K073286Gender Solutions Natural-Knee Flex SystemZimmer, Inc.20085
−2K113369Zimmer Persona Knee SystemZimmer, Inc.201239
−1K122765Persona Natural Tibia BaseplatesZimmer, Inc.20122
0 (this device)K152252Arthrex iBalance TKA SystemArthrex, Inc.2015—
+1K153586Arthrex iBalance TKA SystemArthrex, Inc.2016—
+1K171365Arthrex Knee SystemsArthrex, Inc.2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199510
199620
199710
199810
199910
200010
200120
200510
200710
200810

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201610
201710
FIG. 1 — Lineage of K152252, 1995–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MBH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MBH device

  1. #1 K241597 Freedom® Total Knee System - Porous Tibial…score 20.0 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K081127Accin Total Knee System
Summary page 4
…ame 888.3560: Prosthesis, Knee, Patellofemorotibial, Semi- CFR Constrained, Cemented, Polymer/Metal/Polymer Predicate Device K081127: Accin™ Total Knee System K122765: Zimmer® PersonaTM Knee System Purpose of Submission…
Accelerated Innovation, LLC20081
*K122765Persona Natural Tibia Baseplates
Summary page 4
…CFR Constrained, Cemented, Polymer/Metal/Polymer Predicate Device K081127: Accin™ Total Knee System K122765: Zimmer® PersonaTM Knee System Purpose of Submission This traditional 510(k) premarket notification is…
Zimmer, Inc.20122
*—Arthrex iBalance® TKA System
Named without a submission number
—

Also cleared against K081127: 8 other devices →

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K153586Arthrex iBalance TKA SystemArthrex, Inc.20161
K171365Arthrex Knee SystemsArthrex, Inc.20170

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 20 years and passes through 2 companies; a new generation was cleared every 3.0 years on median.
  • 16 of the 19 ancestors have a recall of any class.
  • Of its descendants, K153586 (Arthrex, Inc., 2016) has gone furthest, with 1 descendant of its own.
  • 8 other devices also cite its predicate K081127.

How does its category compare?

All MBH devices

MBH Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · MBH

8in 2025

2007: 102008: 32009: 32010: 42011: 52012: 52013: 62014: 92015: 82016: 42017: 42018: 62019: 12020: 72021: 62022: 72023: 62024: 102025: 82026 (partial year): 7
2007high 10 (2007) · low 1 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MBH

98in 2025

2007: 59 days median2008: 70 days median2009: 209 days median2010: 84 days median2011: 84 days median2012: 90 days median2013: 138 days median2014: 114 days median2015: 100 days median2016: 74 days median2017: 115 days median2018: 89 days median2020: 112 days median2021: 48 days median2022: 57 days median2023: 94 days median2024: 84 days median2025: 98 days median2026 (partial year): 153 days median
2007high 209 (2009) · low 48 (2021)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MBH

1in 2024

2009: 22011: 152012: 1, 1 Class I2013: 4, 4 Class I2016: 12017: 92018: 12019: 12020: 22023: 22024: 12026 (partial year): 4
2007high 15 (2011) · low 0 (2007)2026

Class I (5 since 2007) Class II/III not classified

Adverse event reports per year · MBH

1,561in 2025

2007: 272008: 212009: 892010: 1212011: 2472012: 3702013: 3082014: 3852015: 9552016: 1,0342017: 1,0072018: 1,1912019: 1,3942020: 1,0892021: 1,5392022: 1,2612023: 1,2632024: 1,4972025: 1,561
2007high 1,561 (2025) · low 21 (2008)2025

MAUDE reports naming product code MBH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071059027
2008370021
20093209289
20104840121
201158415247
20125901 (1)370
201361384 (4)308
201491140385
201581000955
201647411,034
2017411591,007
201868911,191
20191—11,394
2020711221,089
202164801,539
202275701,261
202369421,263
2024108411,497
202589801,561
202671534—

What is it indicated for?

The Arthrex iBalance® TKA System is indicated for use in individuals undergoing surgery for: * Painful, disabling joint disease of the knee resulting from degenerative arthritis, rheumatoid arthritis or post-traumatic arthritis; * Post-traumatic loss of knee joint configuration and function; * Moderate varus, valgus, or flexion deformity in which the ligamentous structures can be returned to adequate function and stability; * Revisions of previous…

Read the full statement (124 words)

The Arthrex iBalance® TKA System is indicated for use in individuals undergoing surgery for:

* Painful, disabling joint disease of the knee resulting from degenerative arthritis, rheumatoid arthritis or post-traumatic arthritis;

* Post-traumatic loss of knee joint configuration and function;

* Moderate varus, valgus, or flexion deformity in which the ligamentous structures can be returned to adequate function and stability;

* Revisions of previous unsuccessful knee replacement or other procedure.

Additional indications for posteriorly stabilization components:

* Ligamentous instability requiring implant bearing surfaces with increased constraint;

* Absent or non-functioning posterior cruciate ligament.

These devices are single use only and are intended for implantation with bone cement, with the exception of porous coated femoral components which can be used cemented or uncemented (biological fixation).

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K152252: Arthrex iBalance TKA System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K152252

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026